We are live on ! Find out more
Eleva Capital

Eleva Capital Portfolio holdings

AUM $113M Turnover 83.72%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$230M
Cap. Flow
-$246M
Cap. Flow %
-217.74%
Top 10 Hldgs %
79.96%
Holding
43
New
19
Increased
4
Reduced
3
Closed
17
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$12.1M
2
AVGO icon
Broadcom
AVGO
+$12M
3
MSFT icon
Microsoft
MSFT
+$10.1M
4
AU icon
AngloGold Ashanti
AU
+$8.48M
5
TBBB icon
BBB Foods
TBBB
+$7.66M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$279M
2
AS icon
Amer Sports
AS
+$9.8M
3
NVDA icon
NVIDIA
NVDA
+$9.6M
4
NFLX icon
Netflix
NFLX
+$8.38M
5
ANET icon
Arista Networks
ANET
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 52.23%
2 Consumer Discretionary 14.91%
3 Materials 8.34%
4 Financials 8.18%
5 Consumer Staples 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RL icon
26
Ralph Lauren
RL
$21.7B
$1.03M 0.91%
+2,889
New +$1.06M
2026 Q3
0 quarters
ACHR icon
27
Archer Aviation
ACHR
$2.28B
– –
-21,534
Closed -$111K –
AQST icon
28
Aquestive Therapeutics
AQST
$435M
– –
-2,720
Closed -$11.3K –
BSX icon
29
Boston Scientific
BSX
$60.8B
– –
-26,667
Closed -$1.67M –
CGON icon
30
CG Oncology
CGON
$7.1B
– –
-8,289
Closed -$561K –
CRH icon
31
CRH
CRH
$58.6B
– –
-2,654,974
Closed -$279M –
ESPR icon
32
DELISTED
Esperion Therapeutics
ESPR
– –
-183,047
Closed -$502K –
EWTX icon
33
Edgewise Therapeutics
EWTX
$4.37B
– –
-17,460
Closed -$55K –
FENC icon
34
Fennec Pharmaceuticals
FENC
$462M
– –
-53,234
Closed -$327K –
IRON icon
35
Disc Medicine
IRON
$3.42B
– –
-5,115
Closed -$327K –
MLYS icon
36
Mineralys Therapeutics
MLYS
$1.21B
– –
-17,081
Closed -$463K –
NAMS icon
37
NewAmsterdam Pharma
NAMS
$2.21B
– –
-25,721
Closed -$823K –
NFLX icon
38
Netflix
NFLX
$233B
– –
-87,190
Closed -$8.38M –
ONON icon
39
On Holding
ONON
$10B
– –
-50,150
Closed -$1.71M –
SPOT icon
40
Spotify
SPOT
$119B
– –
-2,715
Closed -$1.32M –
TMUS icon
41
T-Mobile US
TMUS
$175B
– –
-14,347
Closed -$3.01M –
VRDN icon
42
Viridian Therapeutics
VRDN
$3.4B
– –
-7,126
Closed -$139K –
AS icon
43
Amer Sports
AS
$16.4B
– –
-298,802
Closed -$9.8M –

Similar funds

Eleva Capital's Q3 2026 Portfolio in Review

As of Q3 2026, Eleva Capital held 43 positions worth $113M, down 67% from $343M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Eleva Capital withdrew a net $246M in Q3 2026, closing 17 positions and reducing 3 holdings. Its most notable exit was CRH, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 6.2% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Eleva Capital opened a new position in Broadcom worth $11.2M.

  • Eleva Capital's largest Q3 2026 buy was Broadcom: 31,991 shares worth $11.2M.
  • Eleva Capital added most to Amazon in Q3 2026, an estimated $12.1M increase.
  • Eleva Capital's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $9.6M.
  • Eleva Capital fully exited CRH in Q3 2026, selling an estimated $279M.
  • Eleva Capital's ten largest holdings make up 80% of its $113M portfolio in Q3 2026.
  • Eleva Capital opened 19 new positions and closed 17 in Q3 2026.
  • Eleva Capital's portfolio value fell 67% quarter-over-quarter to $113M.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.